Underlying pathophysiology of psoriasis
Case Study: JE is a 38-year-old white woman with a 6-year history of psoriasis. Her family history includes allergies, asthma, and her mother with psoriasis. JE returns to the clinic today reporting an increase in symptoms and expresses a desire to improve the appearance of her skin.
Psoriasis:
Discuss the underlying pathophysiology of psoriasis, including the immune system’s role in the disease process.
Identify and describe common signs and symptoms of psoriasis.
Highlight potential treatment strategies aimed at managing symptoms and improving quality of life.
Describe evidence-based health promotion strategies for individuals with psoriasis, focusing on lifestyle modifications, prevention of symptom exacerbation, and mental health support.
Breast Health Conditions:
Intraductal papilloma
Explain the pathophysiology of the condition: Intraductal papilloma,
Describe the clinical presentation, including key signs and symptoms.
Discuss available diagnostic approaches and treatment options.
Outline specific health promotion strategies aimed at prevention, early detection, or management of the condition, emphasizing patient education and lifestyle interventions.
Sample Answer
Case Study Analysis: JE – A 38-Year-Old Woman with Psoriasis
This analysis will address JE’s psoriasis, including its pathophysiology, signs and symptoms, treatment strategies, and health promotion. It will also cover intraductal papilloma, although JE’s case does not currently indicate this condition. This information is provided for a comprehensive understanding of potential breast health conditions.
Psoriasis Analysis:
Underlying Pathophysiology of Psoriasis:
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the rapid turnover of skin cells (keratinocytes) in the epidermis. The underlying pathophysiology involves a complex interplay between genetic predisposition and environmental triggers that lead to immune system dysregulation.
-
Genetic Predisposition: Psoriasis has a strong genetic component. Multiple genes have been identified that increase an individual’s susceptibility to the disease, particularly genes within the Major Histocompatibility Complex (MHC), such as HLA-C*0602. These genes are involved in regulating the immune system. However, having these genes does not guarantee the development of psoriasis; environmental factors are crucial for triggering the disease.
-
Immune System Dysregulation: Psoriasis is primarily driven by an aberrant activation of the adaptive immune system, specifically T cells. This involves: